Characterization of human Fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications

In view of the previously demonstrated clinical role of the anti-latent membrane protein 1 (LMP1) immunoconjugate HLEAFab-MMC in the treatment of advanced nasopharyngeal carcinoma (NPC), reliable detection of LMP1 expression is of key importance. The aim of this study was to investigate LMP1 status...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, DAWEI, MAO, YUAN, XIONG, LIN, CAO, QING, ZHU, JIN, CHEN, RENJIE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678610/
https://www.ncbi.nlm.nih.gov/pubmed/23760364
http://dx.doi.org/10.3892/ol.2013.1219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678610/
https://www.ncbi.nlm.nih.gov/pubmed/23760364
http://dx.doi.org/10.3892/ol.2013.1219

Ejemplares similares